Francesco Vendrame is an Endocrinology/Metabolic physician affiliated with University of Miami. OpenAlex indexes 84 publications with 2,743 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 NW 10th Ave Ste 805
Miami, FL 331361031
Telephone
305-243-3636Provider last certified this registry record 13 Nov 2024.
Clinical trials
- Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
Sponsor: Creative Medical Technology Holdings Inc
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Resmed CorpProgram year20251 payment
- Eli Lilly and CompanyProgram year20221 payment
- Lilly USA, LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
69.5%GLP-1 receptor agonist23.5%Ozempic62%Trulicity25%Mounjaro14%Part D≥79 patientsInsulin Analog18.4%Lantus Solostar27%Tresiba Flextouch U-10014%Novolog Flexpen14%Humalog Kwikpen U-1009%Novolog8%Basaglar Kwikpen U-1008%Fiasp Flextouch6%Insulin Lispro Kwikpen U-1004%Levemir Flexpen3%Humalog3%Lyumjev Kwikpen U-1003%Fiasp Penfill3%Part D<11 patients+ 6 more classes in this area
Cardiovascular
17%Statin9.8%Atorvastatin Calcium57%Rosuvastatin Calcium43%Part D≥49 patientsCholesterol absorption inhibitor1.8%Ezetimibe100%Part D≥15 patients+ 6 more classes in this area
Hormonal (systemic)
9.7%l-Thyroxine7.9%Levothyroxine Sodium80%Synthroid20%Part D≥53 patientsAntihypoglycemic Agent1.8%Baqsimi100%Part D≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2022 per NIH RePORTER. The latest:
- Use of use of dimethyl fumarate for targeting autoimmunity in type 1 diabetes
University of Miami School of Medicine
FY2022$191,875R21AI166368 - Use of use of dimethyl fumarate for targeting autoimmunity in type 1 diabetes
University of Miami School of Medicine
FY2021$230,250R21AI166368
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of GAD65 and IA2 autoantibodies on islet allograft survival
Frontiers in Clinical Diabetes and Healthcare
2023 - Comparison of Glycemic Control Between In-Person and Virtual Diabetes Consults in Hospitalized Patients With Diabetes
Journal of Diabetes Science and Technology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”